Tumor and blood specimens profiled with whole-genome (WGS), whole-exome (WES), bulk RNA-seq, and single-cell RNA-seq across multiple timepoints and sequencing providers. These pages give complementary views of the molecular data: raw alignments, gene expression, pathway enrichment, copy-number changes, and the neoantigen targets of personalized vaccines.
End-to-end somatic variant calling on tumor/normal whole-genome and whole-exome sequencing — SNVs, indels, copy number, structural variants, HLA typing, and more from two independent pipelines.
Curated somatic mutations, copy number changes, and neoantigen vaccine targets — plus an interactive genome browser for the underlying sequencing alignments.
Gene expression across bulk and single-cell RNA-seq, with pathway enrichment from the single-cell tumor clusters.
Please contact us with any questions or comments.